Skip to main content
. 2016 Nov 16;7(52):86339–86349. doi: 10.18632/oncotarget.13404

Figure 2. Association between 18q deletion and biochemical (PSA) recurrence in (A) all cancers (n = 6,281), (B) ERG-fusion negative cancers (n = 2,650) and (C) ERG-fusion positive cancers (n = 2,732).

Figure 2